Saxagliptin Treatment Reduces sCD40 Levels and Increases Endothelial Nitric Oxide Bioavailability in Obese, Insulin-Resistant Rats

Autor:	PR Mason, R Kubant, AM Jacoby, RF Jacob, MF Walter, A Bellamine, Y Mizuno, T Malinski
Rok vydání:	2010
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::44d811420a9603581061c4372f4caf22 https://doi.org/10.1210/endo-meetings.2010.part1.p10.p1-487 Zobrazit plný text záznamu